Phase I study of sorafenib in Japanese patients with hepatocellular carcinomaFURUSE, Junji; ISHII, Hiroshi; NAKACHI, Kohei et al.Cancer science. 2008, Vol 99, Num 1, pp 159-165, issn 1347-9032, 7 p.Article

Hepatectomy for Hepatocellular Carcinoma Patients Who Meet the Milan CriteriaISHII, Hiroshi; FURUSE, Junji; KINOSHITA, Taira et al.Hepato-gastroenterology. 2008, Vol 55, Num 82-83, pp 621-626, issn 0172-6390, 6 p.Article

DOSE―VOLUME HISTOGRAM ANALYSIS OF THE SAFETY OF PROTON BEAM THERAPY FOR UNRESECTABLE HEPATOCELLULAR CARCINOMAKAWASHIMA, Mitsuhiko; KOHNO, Ryosuke; ZENDA, Sadamoto et al.International journal of radiation oncology, biology, physics. 2011, Vol 79, Num 5, pp 1479-1486, issn 0360-3016, 8 p.Article

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinomaKUDO, Masatoshi; IMANAKA, Kazuho; KANEKO, Shuichi et al.European journal of cancer (1990). 2011, Vol 47, Num 14, pp 2117-2127, issn 0959-8049, 11 p.Article

A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancerMORIZANE, Chigusa; OKUSAKA, Takuji; FURUSE, Junji et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 2, pp 313-319, issn 0344-5704, 7 p.Article

A phase i study of hypofractionated radiotherapy followed by systemic chemotherapy with full-dose gemcitabine in patients with unresectable locally advanced pancreatic cancerFURUSE, Junji; ISHII, Hiroshi; KAWASHIMA, Mitsuhiko et al.Hepato-gastroenterology. 2007, Vol 54, Num 77, pp 1575-1578, issn 0172-6390, 4 p.Article

Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytesNOBLJOKA, Daisuke; MOTOMURA, Yutaka; TAKAHASHI, Shinichiro et al.International journal of oncology. 2012, Vol 40, Num 1, pp 63-70, issn 1019-6439, 8 p.Article

Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancerOKUSAKA, Takuji; FURUSE, Junji; ITO, Tetsuhide et al.Cancer science. 2011, Vol 102, Num 2, pp 425-431, issn 1347-9032, 7 p.Article

A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancerUENO, Hideki; OKUSAKA, Takuji; IKEDA, Masafumi et al.Oncology. 2005, Vol 69, Num 5, pp 421-427, issn 0030-2414, 7 p.Article

Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancerIMOTO, Akira; MITSUNAGA, Shuichi; INAGAKI, Masatoshi et al.International journal of cancer (Print). 2012, Vol 131, Num 12, pp 2795-2807, issn 0020-7136, 13 p.Article

Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinomaFURUSE, Junji; OKUSAKA, Takuji; KANEKO, Shuichi et al.Cancer science. 2010, Vol 101, Num 12, pp 2606-2611, issn 1347-9032, 6 p.Article

Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinomaIKEDA, Masafumi; SHIINA, Shuichiro; ASAOKA, Yoshinari et al.Investigational new drugs. 2014, Vol 32, Num 5, pp 928-936, issn 0167-6997, 9 p.Article

Phase I Trial of a Glypican-3―Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall SurvivalSAWADA, Yu; YOSHIKAWA, Toshiaki; NAKAGOHRI, Toshio et al.Clinical cancer research (Print). 2012, Vol 18, Num 13, pp 3686-3696, issn 1078-0432, 11 p.Article

Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patientsMORIZANE, Chigusa; OKUSAKA, Takuji; SUZUKI, Eiichiro et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 4, pp 957-964, issn 0344-5704, 8 p.Article

A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancerNAKACHI, Kohei; FURUSE, Junji; KINOSHITA, Taira et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 3, pp 527-534, issn 0344-5704, 8 p.Article

Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 CasesSUZUKI, Eiichiro; FURUSE, Junji; KOJIMA, Yasushi et al.Oncology. 2010, Vol 79, Num 1-2, pp 39-45, issn 0030-2414, 7 p.Article